Cargando…

Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease

BACKGROUND: Quality indicators are crucial in evaluating and comparing the quality of healthcare services. In the case of congenital heart disease, transition programmes for adolescents have been recommended to ensure uninterrupted healthcare and lifelong care. It is necessary to establish quality i...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomet, Corina, Moons, Philip, Schwerzmann, Markus, Schwitz, Fabienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601126/
https://www.ncbi.nlm.nih.gov/pubmed/37880667
http://dx.doi.org/10.1186/s12913-023-10183-6
_version_ 1785126130782568448
author Thomet, Corina
Moons, Philip
Schwerzmann, Markus
Schwitz, Fabienne
author_facet Thomet, Corina
Moons, Philip
Schwerzmann, Markus
Schwitz, Fabienne
author_sort Thomet, Corina
collection PubMed
description BACKGROUND: Quality indicators are crucial in evaluating and comparing the quality of healthcare services. In the case of congenital heart disease, transition programmes for adolescents have been recommended to ensure uninterrupted healthcare and lifelong care. It is necessary to establish quality indicators in order to facilitate the evaluation of programme quality and to allow comparison between different centres. The objective of this study is therefore to develop a set of quality indicators for the transition of adolescents with congenital heart disease. METHODS: The RAND/UCLA appropriateness method was employed in a four-step process to develop a set of quality indicators. First, a literature search was conducted on the dimensions of transitional care, based on which a preliminary set of quality indicators was developed. Second, experts were contacted, and an expert panel was established. Third, the panel members were asked to rate the appropriateness of the quality indicators in a two-round process. Finally, in the fourth step, we evaluated the data by measuring the median and Disagreement Index. RESULTS: The expert panel consisted of 16 members, congenital cardiologists, nurses, transition experts, patients and research experts. The preliminary set of quality indicators comprised 16 items, categorized in process and structure criteria. Based on the panel’s feedback, the set was refined to 12 quality indicators, which were rated as relevant and feasible. CONCLUSIONS: This study represents the first attempt to develop quality indicators for transitional care services for adolescents with congenital heart disease. The set of 12 quality indicators was developed based on existing evidence and expert opinion. Further testing is needed to assess the feasibility of these quality indicators in daily practice. If successfully implemented, these quality indicators could allow comparison and facilitate benchmarking of transitional care services for adolescents with congenital heart disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-10183-6.
format Online
Article
Text
id pubmed-10601126
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106011262023-10-27 Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease Thomet, Corina Moons, Philip Schwerzmann, Markus Schwitz, Fabienne BMC Health Serv Res Research BACKGROUND: Quality indicators are crucial in evaluating and comparing the quality of healthcare services. In the case of congenital heart disease, transition programmes for adolescents have been recommended to ensure uninterrupted healthcare and lifelong care. It is necessary to establish quality indicators in order to facilitate the evaluation of programme quality and to allow comparison between different centres. The objective of this study is therefore to develop a set of quality indicators for the transition of adolescents with congenital heart disease. METHODS: The RAND/UCLA appropriateness method was employed in a four-step process to develop a set of quality indicators. First, a literature search was conducted on the dimensions of transitional care, based on which a preliminary set of quality indicators was developed. Second, experts were contacted, and an expert panel was established. Third, the panel members were asked to rate the appropriateness of the quality indicators in a two-round process. Finally, in the fourth step, we evaluated the data by measuring the median and Disagreement Index. RESULTS: The expert panel consisted of 16 members, congenital cardiologists, nurses, transition experts, patients and research experts. The preliminary set of quality indicators comprised 16 items, categorized in process and structure criteria. Based on the panel’s feedback, the set was refined to 12 quality indicators, which were rated as relevant and feasible. CONCLUSIONS: This study represents the first attempt to develop quality indicators for transitional care services for adolescents with congenital heart disease. The set of 12 quality indicators was developed based on existing evidence and expert opinion. Further testing is needed to assess the feasibility of these quality indicators in daily practice. If successfully implemented, these quality indicators could allow comparison and facilitate benchmarking of transitional care services for adolescents with congenital heart disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-10183-6. BioMed Central 2023-10-25 /pmc/articles/PMC10601126/ /pubmed/37880667 http://dx.doi.org/10.1186/s12913-023-10183-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Thomet, Corina
Moons, Philip
Schwerzmann, Markus
Schwitz, Fabienne
Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
title Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
title_full Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
title_fullStr Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
title_full_unstemmed Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
title_short Development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
title_sort development of quality indicators of transfer and transition in adolescents and young adults with congenital heart disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601126/
https://www.ncbi.nlm.nih.gov/pubmed/37880667
http://dx.doi.org/10.1186/s12913-023-10183-6
work_keys_str_mv AT thometcorina developmentofqualityindicatorsoftransferandtransitioninadolescentsandyoungadultswithcongenitalheartdisease
AT moonsphilip developmentofqualityindicatorsoftransferandtransitioninadolescentsandyoungadultswithcongenitalheartdisease
AT schwerzmannmarkus developmentofqualityindicatorsoftransferandtransitioninadolescentsandyoungadultswithcongenitalheartdisease
AT schwitzfabienne developmentofqualityindicatorsoftransferandtransitioninadolescentsandyoungadultswithcongenitalheartdisease